Skip to main content
Tech.euFundingExplorerBeta

Core Biogenesis

Core Biogenesis fights against cancer and neurodegenerative diseases

Total raised
€20M
€20,274,515
Funding rounds
2
Investors
5
distinct backers
Active since
2022-03
latest 2022-07

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood32
base rate 44% for Series A
  • Overdue vs cohort gap
  • Low backer re-investment
Exit likelihood12
base rate 12% (2+ rounds)

    Timing: overdue vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.

    Funding rounds

    2 rounds

    Similar companies

    same sector or country